Nasty or Nice? A Perspective on the Use of Health Technology Assessment in the United Kingdom

[11] Economic evaluation and decision making in the UK [J]. PHARMACOECONOMICS, 2006, 24 (11) : 1133 - 1142

[12] Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared [J]. HEALTH POLICY, 2006, 76 (02) : 134 - 143

[13] OFT, VBP: QED? [J]. HEALTH ECONOMICS, 2007, 16 (06) : 545 - 558

[14] *COMM AUSTR, 2006, GUID PREP SUBM PBAC

[15] Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567

[16] Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J]. HEALTH ECONOMICS, 2004, 13 (05) : 437 - 452

[17] Donaldson C, 2006, ELGAR ORIG REF, P392

[18] DRUMMOND MF, INT J TECHNOL ASSESS, V23, P36

[19] Drummond MF, 2005, Methods for The Economic Evaluation of Health Care Programmes

[20] MARTIN S, 2007, 24 CHE U YORK

[11] Economic evaluation and decision making in the UK [J]. PHARMACOECONOMICS, 2006, 24 (11) : 1133 - 1142

[12] Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared [J]. HEALTH POLICY, 2006, 76 (02) : 134 - 143

[13] OFT, VBP: QED? [J]. HEALTH ECONOMICS, 2007, 16 (06) : 545 - 558

[14] *COMM AUSTR, 2006, GUID PREP SUBM PBAC

[15] Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567

[16] Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J]. HEALTH ECONOMICS, 2004, 13 (05) : 437 - 452

[17] Donaldson C, 2006, ELGAR ORIG REF, P392

[18] DRUMMOND MF, INT J TECHNOL ASSESS, V23, P36

[19] Drummond MF, 2005, Methods for The Economic Evaluation of Health Care Programmes

[20] MARTIN S, 2007, 24 CHE U YORK